Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Drug Discovery 8, 537 (1 July 2009) | doi:10.1038/nrd2932
Inflammatory diseases: Targeting prostanoid receptors
Abstract
A paper published in Nature Medicine has shown that the G protein-coupled prostanoid EP4 receptor might be a new target for immuno-inflammatory disorders. TH1 and TH17 T helper cells mediate tissue damage and inflammation and are crucial to the pathogenesis of various immune disorders.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
